A032302 Docetaxel Addition in mCRPC (ASPIRE)

Study Details

Full Title

Protocol A032302 Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)

Principal Investigator

Hannah
McManus

Protocol Number

PRO00119563

NCT ID

NCT06931340

Phase

III

Enrollment Status

Open to Enrollment